Can your phone help your heart? new study tests apps and texts for heart failure
NCT ID NCT06205225
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is testing whether using mobile health apps and receiving tailored text messages can help people with chronic heart failure take better care of themselves and avoid hospital stays. Researchers will enroll 360 adults with Stage C heart failure and randomly assign them to use apps, receive texts, both, or standard care. The goal is to see if these digital tools improve self-care and reduce days lost to heart-related hospitalizations or death.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- mobile health apps and tailored text messages
- What this could lead to
- If successful, this could provide a low-cost, scalable way for heart failure patients to better manage their condition at home and reduce hospital visits.
- What could go wrong
- This is a behavioral intervention study, not a drug trial, so benefits may be modest. Results depend on patient engagement and may not apply to everyone with heart failure.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 360 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Oct 2024
- Expected to finish
-
Sep 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Diagnosis of Stage C Heart Failure * ≥ 18 years of age * Transthoracic Echocardiogram or Cardiac MRI performed in the last 3 years and LVEF results available * Patient is actively treated with oral loop diuretics for chronic heart failure * Hospitalization due to acute decompensated heart failure within 24 months before randomization and/or insufficient self-care per SCHFI assessment (score of ≤3, in at least two items of the SCHFI v7.2 maintenance, symptom monitoring, or self-care management subscale) * Ability to speak and read English Exclusion Criteria: * Implanted ventricular assist device * High urgent listed for heart transplantation * Acute coronary syndrome within the last 7 days before randomization * Revascularization and/or CRT implantation within 28 days before randomization * Planned revascularization, transcatheter aortic valve implantation, MitraClip and/or CRT implantation within 3 months after randomization * End-stage HF (hospice candidate) * Discharge to a setting other than home * Individuals who have a home nurse or are not able to take care of self (eat, dress, walk, bathe, take medications, or use the toilet) * Chronic renal insufficiency with hemodialysis or estimated Glomerular Filtration Rate \<25 mL * Active cancer, currently undergoing treatment (e.g. radiation immunotherapy) * Existence of any disease reducing life expectancy to less than 1 year * Cognitive impairment (e.g., Dementia, Parkinson disease, Alzheimer disease, MoCA\<18, impaired self-determination, lacking ability to communicate) * Major physical impairment (e.g., inability to walk, bound on a wheelchair) * Unwillingness to use study equipment * Active substance abuse * Currently pregnant, less than 3-month post-partum or pregnancy anticipated during the study * Participation in other treatment studies or remote patient management programs * Participation in the iCardia4H pilot trial (conducted before this study)
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Chronic heart failure are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
2 sites. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Rush University Medical Center
RECRUITINGChicago, Illinois, 60612, United States
-
University of Illinois Hospital & Health Sciences System
RECRUITINGChicago, Illinois, 60612, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can an inhaler boost heart pumping in COPD patients?
- Can zapping the heart beat drugs for AF in heart failure?
- Which SGLT2 inhibitor wins? trial pits empagliflozin against dapagliflozin
- Can daily mindful breathing ease heart failure symptoms?
- Can a smartphone app keep heart failure patients out of the hospital?
- Can better training get doctors to talk about what matters most to dying veterans?